Director, GMT

Overview The Clinton Health Access Initiative , Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems. CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally. At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication, and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture. Team Overview The CHAI Global Markets Team (GMT) supports CHAI’s diverse programs in achieving sustainable access to best-in-class drugs and diagnostic tests. GMT is responsible for leading, designing, negotiating, and supporting the effective implementation of market shaping interventions and access programs that increase the uptake of critical health commodities in LMICs. Market-shaping interventions range from traditional policy-led and grant-financed initiatives such as pooled procurement, coordinated ordering, and strategic demand forecasting to more innovative mechanisms such as volume guarantees (VGs), product development incentives, advance market commitments (AMCs), and working capital facilities. Examples of programs developed and led by GMT include the following: - CHAI in partnership with DRL announced HIV prevention drug Lenacapavir to be launched at $40. This is pathbreaking, and President Clinton announced this himself at UNGA 2026. A generic version of the drug will be made available in record time. - CHAI and The Hepatitis Fund announce pricing breakthrough to reduce cost of viral hepatitis treatment by over 90 percent - New agreement secures historic US$1 price for HIV self-test - Global partnership to make available 120M affordable, quality COVID-19 rapid tests for low- and middle-income countries - Price reduction agreement for contraceptive implants increased distribution by >50% and will save more than US$300M The GMT collaborates with internal and external stakeholders on both the supply- and demand-sides of the market to assess the potential public-health impact of proposed market-shaping interventions. The GMT also takes the lead within CHAI in developing access programs and managi